Gyon Technologies Capital Management, LP Zymeworks Inc. Transaction History

Gyon Technologies Capital Management, LP

  • $0
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$15.19 - $29.33 $512,465 - $989,506
-33,737 Closed
0 $0
Q3 2021

Nov 18, 2021
BUY
$27.35 - $37.28 $922,706 - $1.26 Million
33,737 New
33,737 $980,000
Q3 2020

Nov 16, 2020
SELL
$29.21 - $46.58 $529,343 - $844,122
-18,122 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$33.67 - $40.0 $610,167 - $724,880
18,122 New
18,122 $654,000

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $895M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email